{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:45:17Z","timestamp":1789764317721,"version":"4.0.1"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11910-018-0890-y","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T02:53:58Z","timestamp":1538708038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Novel Imaging Biomarkers for Huntington\u2019s Disease and Other Hereditary Choreas"],"prefix":"10.1007","volume":"18","author":[{"given":"Patrik","family":"Fazio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Paucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Varrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"issue":"4","key":"890_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11910-011-0202-2","volume":"11","author":"Ruth H. Walker","year":"2011","unstructured":"Walker, R.H. Differential diagnosis of chorea. Curr Neurol Neurosci Rep. 2011;11:385. https:\/\/doi.org\/10.1007\/s11910-011-0202-2 .","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"6","key":"890_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"M MACDONALD","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971\u2013983. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E .","journal-title":"Cell"},{"key":"890_CR3","volume-title":"Huntington\u2019s disease","author":"G Bates","year":"2014","unstructured":"Bates G, Tabrizi S, Jones L. Huntington\u2019s disease, no. 64. USA: Oxford University Press; 2014."},{"issue":"5","key":"890_CR4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney JB, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol. 1997;41(5):689\u201392.","journal-title":"Ann Neurol"},{"issue":"5","key":"890_CR5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.21915","volume":"23","author":"EJ Wild","year":"2008","unstructured":"\u2022\u2022 Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, et al. Huntington\u2019s disease phenocopies are clinically and genetically heterogeneous. Mov Disord. 2008;23(5):716\u201320 A comprehensive clinically oriented discussion on possible HD phenocopies.","journal-title":"Mov Disord"},{"issue":"4","key":"890_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0000000000000061","volume":"82","author":"DJ Hensman Moss","year":"2014","unstructured":"\u2022 Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 2014;82(4):292\u20139 This study extends the known phenotype of the C9orf72 expansion as the most common HD phenocopies.","journal-title":"Neurology"},{"issue":"1","key":"890_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40734-017-0056-0","volume":"4","author":"DJ Ehrlich","year":"2017","unstructured":"Ehrlich DJ, Walker RH. Functional neuroimaging and chorea: a systematic review. J Clin Mov Disord. 2017;4(1):8.","journal-title":"J Clin Mov Disord"},{"issue":"Pt 3","key":"890_CR8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/brain\/awr361","volume":"135","author":"CJ Mahoney","year":"2012","unstructured":"Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135(Pt 3):736\u201350.","journal-title":"Brain"},{"issue":"3","key":"890_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ajhg.2013.01.011","volume":"92","author":"J Beck","year":"2013","unstructured":"Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet. 2013;92(3):345\u201353.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"890_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0891988710383576","volume":"23","author":"K Brown","year":"2010","unstructured":"Brown K, Mastrianni JA. The prion diseases. J Geriatr Psychiatry Neurol. 2010;23(4):277\u201398.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"890_CR11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/302093","volume":"63","author":"F Xiang","year":"1998","unstructured":"Xiang F, Almqvist EW, Huq M, Lundin A, Hayden MR, Edstrom L, et al. A Huntington disease-like neurodegenerative disorder maps to chromosome 20p. Am J Hum Genet. 1998;63(5):1431\u20138.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"890_CR12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/324414","volume":"69","author":"RC Moore","year":"2001","unstructured":"Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edstr\u00f6m L, et al. Huntington disease phenocopy is a familial prion disease. Am J Hum Genet. 2001;69(6):1385\u20138.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"890_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.1312","volume":"50","author":"RL Margolis","year":"2001","unstructured":"Margolis RL, O\u2019Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, et al. A disorder similar to Huntington\u2019s disease is associated with a novel CAG repeat expansion. Ann Neurol. 2001;50(6):373\u201380.","journal-title":"Ann Neurol"},{"issue":"1","key":"890_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JHD-160232","volume":"6","author":"DG Anderson","year":"2017","unstructured":"Anderson DG, Walker RH, Connor M, Carr J, Margolis RL, Krause A. A systematic review of the Huntington disease-like 2 phenotype. J Huntingtons Dis. 2017;6(1):37\u201346.","journal-title":"J Huntingtons Dis"},{"issue":"11","key":"890_CR15","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/hmg\/8.11.2047","volume":"8","author":"R Koide","year":"1999","unstructured":"Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet. 1999;8(11):2047\u201353.","journal-title":"Hum Mol Genet"},{"key":"890_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-319-71779-1_10","volume":"1049","author":"Y Toyoshima","year":"2018","unstructured":"Toyoshima Y, Takahashi H. Spinocerebellar ataxia type 17 (SCA17). Adv Exp Med Biol. 2018;1049:219\u201331.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"890_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/jmg.2003.015602","volume":"41","author":"P Bauer","year":"2004","unstructured":"Bauer P, Laccone F, Rolfs A, W\u00fcllner U, B\u00f6sch S, Peters H, et al. Trinucleotide repeat expansion in SCA17\/TBP in white patients with Huntington\u2019s disease-like phenotype. J Med Genet. 2004;41(3):230\u20132.","journal-title":"J Med Genet"},{"issue":"8","key":"890_CR18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/hmg\/11.8.971","volume":"11","author":"GJ Breedveld","year":"2002","unstructured":"Breedveld GJ, van Dongen JWF, Danesino C, Guala A, Percy AK, Dure LS, et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet. 2002;11(8):971\u20139.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"890_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00431-004-1559-x","volume":"164","author":"MAAP Willemsen","year":"2005","unstructured":"Willemsen MAAP, Breedveld GJ, Wouda S, Otten BJ, Yntema JL, Lammens M, et al. Brain-thyroid-lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr. 2005;164(1):28\u201330.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"890_CR20","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/hmg\/ddp162","volume":"18","author":"A Carr\u00e9","year":"2009","unstructured":"Carr\u00e9 A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, Broutin-L\u2019Hermite I, et al. Five new TTF1\/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet. 2009;18(12):2266\u201376.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"890_CR21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archneurol.2012.54","volume":"69","author":"Y-Z Chen","year":"2012","unstructured":"Chen Y-Z, Matsushita MM, Robertson P, Rieder M, Girirajan S, Antonacci F, et al. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol. 2012;69(5):630\u20135.","journal-title":"Arch Neurol"},{"issue":"7","key":"890_CR22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mds.26598","volume":"31","author":"FCF Chang","year":"2016","unstructured":"Chang FCF, Westenberger A, Dale RC, Smith M, Pall HS, Perez-Due\u00f1as B, et al. Phenotypic insights into ADCY5-associated disease. Mov Disord. 2016;31(7):1033\u201340.","journal-title":"Mov Disord"},{"issue":"2","key":"890_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/01.wnl.0000250356.78092.cc","volume":"68","author":"R. H. Walker","year":"2007","unstructured":"R. H. Walker, H. H. Jung, C. Dobson-Stone, L. Rampoldi, A. Sano, F. Tison, and A. Danek, Neurologic phenotypes associated with acanthocytosis, Neurology, vol. 68, 2007.","journal-title":"Neurology"},{"issue":"1","key":"890_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/mds.22863","volume":"25","author":"Benedikt Bader","year":"2009","unstructured":"Bader B, Walker RH, Vogel M, Prosiegel M, McIntosh J and Danek A. Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis, Mov Disord. 2010;15;25(1):127\u20139. https:\/\/doi.org\/10.1002\/mds.22863 .","journal-title":"Movement Disorders"},{"issue":"11","key":"890_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ejmg.2017.12.007","volume":"61","author":"Kevin Peikert","year":"2018","unstructured":"Peikert K, Danek A, Hermann A.Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome. Eur J Med Genet. 2017. https:\/\/doi.org\/10.1016\/j.ejmg.2017.12.007 .","journal-title":"European Journal of Medical Genetics"},{"key":"890_CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-444-52014-2.00009-4","volume":"100","author":"A McNeill","year":"2011","unstructured":"McNeill A, Chinnery PF. Neurodegeneration with brain iron accumulation. Handb Clin Neurol. 2011;100:161\u201372.","journal-title":"Handb Clin Neurol"},{"key":"890_CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-444-63233-3.00019-1","volume-title":"Neurogenetics, Part I","author":"SJ Hayflick","year":"2018","unstructured":"Hayflick SJ, Kurian MA, Hogarth P. Chapter 19\u2014neurodegeneration with brain iron accumulation. In: Geschwind DH, Paulson HL, Klein C, editors. Neurogenetics, Part I, vol. 147. New York: Elsevier; 2018. p. 293\u2013305."},{"issue":"4","key":"890_CR28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/WCO.0000000000000352","volume":"29","author":"NE Mencacci","year":"2016","unstructured":"Mencacci NE, Carecchio M. Recent advances in genetics of chorea. Curr Opin Neurol. 2016;29(4):486\u201395.","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"890_CR29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/mds.26013","volume":"29","author":"EH Aylward","year":"2014","unstructured":"Aylward EH. Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington\u2019s disease. Mov Disord. 2014;29(11):1429\u201333.","journal-title":"Mov Disord"},{"issue":"4","key":"890_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10(4):204\u201316.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"890_CR31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"\u2022\u2022 Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8(9):791\u2013801 This multicenter study included data from 366 individuals (123 controls, 120 premanifest (pre-HD) individuals, and 123 patients with early HD) with an extensive battery of assessments (multi-site 3T MRI, clinical, cognitive, quantitative motor, oculomotor, and neuropsychiatric measures). The results provided robust evidences of significant changes in grey and white matter brain volumes and impairment in oculomotor tasks and cognitive and neuropsychiatric dysfunction in premanifest and early symptomatic HD gene carriers with normal motor scores.","journal-title":"Lancet Neurol"},{"issue":"1","key":"890_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"\u2022\u2022 Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10(1):31\u201342 The longitudinal part of the TRACK-HD study that included 116 pre-HD individuals, 114 early HD patients, and 115 people that completed follow-up. After 12\u00a0months quantitative imaging showed the greatest differentiation across the spectrum of disease and functional measures were sensitive in early HD, with cognitive and quantitative motor impairment that were detectable in presymptomatic HD gene mutation carriers.","journal-title":"Lancet Neurol"},{"issue":"4","key":"890_CR33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","volume":"82","author":"EH Aylward","year":"2011","unstructured":"\u2022\u2022 Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2011;82(4):405\u201310 This study was designed to examine the potential utility of structural MRI measures as outcome measures for clinical trials. Data are presented from 211 prodromal individuals and 60 controls, scanned both at baseline and at the 2-year follow-up. The obtained results suggested that presymptomatic HD mutation carriers with an expected motor onset within 15\u00a0years showed a larger disease-related atrophy in white matter than in striatum if the age-related changes were taken into account.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"890_CR34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, et al. Detection of Huntington\u2019s disease decades before diagnosis: the predict-HD study. J Neurol Neurosurg Psychiatry. Aug. 2008;79(8):874\u201380.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"890_CR35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neubiorev.2013.01.022","volume":"37","author":"N Georgiou-Karistianis","year":"2013","unstructured":"Georgiou-Karistianis N, Scahill R, Tabrizi SJ, Squitieri F, Aylward E. Structural MRI in Huntington\u2019s disease and recommendations for its potential use in clinical trials. Neurosci Biobehav Rev. 2013;37(3):480\u201390.","journal-title":"Neurosci Biobehav Rev"},{"key":"890_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume-title":"Handbook of Clinical Neurology","author":"Jean Paul G. Vonsattel","year":"2011","unstructured":"Vonsattel JPG, Keller C, and Cortes Ramirez EP. Huntington's disease - neuropathology. Handb Clin Neurol. 2011;100:83\u2013100. https:\/\/doi.org\/10.1016\/B978-0-444-52014-2.00004-5 ."},{"issue":"9","key":"890_CR37","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/mds.23747","volume":"26","author":"NZ Hobbs","year":"2011","unstructured":"Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, et al. The structural involvement of the cingulate cortex in premanifest and early Huntington\u2019s disease. Mov Disord. 2011;26(9):1684\u201390.","journal-title":"Mov Disord"},{"issue":"6","key":"890_CR38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.57.6.1025","volume":"57","author":"HD Rosas","year":"2001","unstructured":"Rosas HD, Goodman J, Chen YI, Jenkins BG, Kennedy DN, Makris N, et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology. 2001;57(6):1025\u20138.","journal-title":"Neurology"},{"issue":"24","key":"890_CR39","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1212\/WNL.0b013e3182020123","volume":"75","author":"N Bechtel","year":"2010","unstructured":"Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJA, Jauffret C, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010;75(24):2150\u201360.","journal-title":"Neurology"},{"issue":"Pt 4","key":"890_CR40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, et al. Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain. 2008;131(Pt 4):1057\u201368.","journal-title":"Brain"},{"issue":"10","key":"890_CR41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1212\/WNL.0000000000000187","volume":"82","author":"HD Rosas","year":"2014","unstructured":"Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu J-P, et al. PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease. Neurology. 2014;82(10):850\u20137.","journal-title":"Neurology"},{"issue":"1","key":"890_CR42","doi-asserted-by":"crossref","first-page":"547.e13","DOI":"10.1016\/j.neurobiolaging.2014.08.020","volume":"36","author":"G Koutsis","year":"2015","unstructured":"Koutsis G, Karadima G, Kartanou C, Kladi A, Panas M. C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population. Neurobiol Aging. 2015;36(1):547.e13\u20136.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"890_CR43","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00415-014-7430-8","volume":"261","author":"VS Kostic","year":"2014","unstructured":"Kostic VS, Dobricic V, Stankovic I, Ralic V, Stefanova E. C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome. J Neurol. 2014;261(10):1917\u201321.","journal-title":"J Neurol"},{"issue":"3","key":"890_CR44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/brain\/aws001","volume":"135","author":"JL Whitwell","year":"2012","unstructured":"Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain. 2012;135(3):794\u2013806.","journal-title":"Brain"},{"key":"890_CR45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.nicl.2016.10.014","volume":"12","author":"MK Floeter","year":"2016","unstructured":"Floeter MK, Bageac D, Danielian LE, Braun LE, Traynor BJ, Kwan JY. Longitudinal imaging in C9orf72 mutation carriers: relationship to phenotype. NeuroImage Clin. 2016;12:1035\u201343.","journal-title":"NeuroImage Clin"},{"issue":"3","key":"890_CR46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(14)70233-9","volume":"14","author":"JD Rohrer","year":"2015","unstructured":"Rohrer JD, Isaacs AM, Mizielinska S, Mead S, Lashley T, Wray S, et al. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2015;14(3):291\u2013301.","journal-title":"Lancet Neurol"},{"key":"890_CR47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnagi.2018.00045","volume":"10","author":"S Sch\u00f6necker","year":"2018","unstructured":"Sch\u00f6necker S, Neuhofer C, Otto M, Ludolph A, Kassubek J, Landwehrmeyer B, et al. Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS patients\u2014an atlas-based volumetric MRI study. Front Aging Neurosci. 2018;10:45.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"890_CR48","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/WNL.0b013e318268452e","volume":"79","author":"SJ Sha","year":"2012","unstructured":"Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology. 2012;79(10):1002\u201311.","journal-title":"Neurology"},{"issue":"6","key":"890_CR49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4161\/pri.27260","volume":"7","author":"M Paucar","year":"2013","unstructured":"Paucar M, Xiang F, Moore R, Walker R, Winnberg E, Svenningsson P. Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation. Prion. 2013;7(6):501\u201310.","journal-title":"Prion"},{"key":"890_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nicl.2016.10.021","volume":"13","author":"E Vita","year":"2016","unstructured":"Vita E, Ridgway GR, White MJ, Porter MC, Caine D, Rudge P. De neuroanatomical correlates of prion disease progression-a 3T longitudinal voxel-based morphometry study. Neuroimage Clin. 2016;13:89\u201396.","journal-title":"Neuroimage Clin"},{"issue":"Pt 9","key":"890_CR51","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/awl226","volume":"129","author":"S Mead","year":"2006","unstructured":"Mead S, Poulter M, Beck J, Webb TEF, Campbell TA, Linehan JM, et al. Inherited prion disease with six octapeptide repeat insertional mutation\u2014molecular analysis of phenotypic heterogeneity. Brain. 2006;129(Pt 9):2297\u2013317.","journal-title":"Brain"},{"issue":"7","key":"890_CR52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.2006.094821","volume":"78","author":"RG Macfarlane","year":"2007","unstructured":"Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, J\u00e4ger HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry. 2007;78(7):664\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"890_CR53","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.20529","volume":"20","author":"Clement T. Loy","year":"2005","unstructured":"Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, et al. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord. 20(11):1521\u20133.","journal-title":"Movement Disorders"},{"key":"890_CR54","volume-title":"The differential diagnosis of chorea","author":"OR Adam","year":"2011","unstructured":"Adam OR, Jankovic J. Benign hereditary chorea. In: Walker RH, editor. The differential diagnosis of chorea. Oxford: Oxford University Press; 2011."},{"issue":"4","key":"890_CR55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10048-005-0013-1","volume":"6","author":"M Carmo Costa do","year":"2005","unstructured":"do Carmo Costa M, Costa C, Silva AP, Evangelista P, Santos L, Ferro A, et al. Nonsense mutation in TITF1 in a Portuguese family with benign hereditary chorea. Neurogenetics. 2005;6(4):209\u201315.","journal-title":"Neurogenetics"},{"issue":"1","key":"890_CR56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.0000000000001720","volume":"85","author":"NE Mencacci","year":"2015","unstructured":"Mencacci NE, Erro R, Wiethoff S, Hersheson J, Ryten M. ADCY5 mutations are another cause of benign hereditary chorea. Neurology. 2015;85(1):80\u20138.","journal-title":"Neurology"},{"issue":"6","key":"890_CR57","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1167\/iovs.04-0539","volume":"46","author":"L Gradstein","year":"2005","unstructured":"Gradstein L, Danek A, Grafman J, Fitzgibbon EJ. Eye movements in chorea-acanthocytosis. Invest Ophthalmol Vis Sci. 2005;46(6):1979\u201387.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"890_CR58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pscychresns.2010.10.006","volume":"192","author":"M Walterfang","year":"2011","unstructured":"Walterfang M, Looi JCL, Styner M, Walker RH, Danek A, Niethammer M, et al. Shape alterations in the striatum in chorea-acanthocytosis. Psychiatry Res. 2011;192(1):29\u201336.","journal-title":"Psychiatry Res"},{"issue":"17","key":"890_CR59","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1212\/WNL.0b013e3181bd80d4","volume":"73","author":"R Scheid","year":"2009","unstructured":"Scheid R, Bader B, Ott DV, Merkenschlager A, Danek A. Development of mesial temporal lobe epilepsy in chorea-acanthocytosis. Neurology. 2009;73(17):1419\u201322.","journal-title":"Neurology"},{"issue":"1","key":"890_CR60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870130121","volume":"13","author":"M Tanaka","year":"1998","unstructured":"Tanaka M, Hirai S, Kondo S, Sun X, Nakagawa T, Tanaka S, et al. Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study. Mov Disord. 1998;13(1):100\u20137.","journal-title":"Mov Disord"},{"issue":"2","key":"890_CR61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3174\/ajnr.A1282","volume":"30","author":"T Katsube","year":"2009","unstructured":"Katsube T, Shimono T, Ashikaga R, Hosono M, Kitagaki H, Murakami T. Demonstration of cerebellar atrophy in neuroacanthocytosis of 2 siblings. AJNR Am J Neuroradiol. 2009;30(2):386\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"890_CR62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00415-010-5725-y","volume":"258","author":"J-H Lee","year":"2011","unstructured":"Lee J-H, Lee S-M, Baik S-K. Demonstration of striatopallidal iron deposition in chorea-acanthocytosis by susceptibility-weighted imaging. J Neurol. 2011;258(2):321\u20132.","journal-title":"J Neurol"},{"key":"890_CR63","doi-asserted-by":"crossref","unstructured":"Danek A, Rubio JP, Rampoldi L, HoM, Dobson-Stone C, Tison F, Symmans WA, Oechsner M, KalckreuthW and Watt JM. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol. 2001; 50(6):755\u201364.","DOI":"10.1002\/ana.10035"},{"issue":"4","key":"890_CR64","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1468-1331.2009.02872.x","volume":"17","author":"PO Valko","year":"2010","unstructured":"Valko PO, H\u00e4nggi J, Meyer M, Jung HH. Evolution of striatal degeneration in McLeod syndrome. Eur J Neurol. 2010;17(4):612\u20138.","journal-title":"Eur J Neurol"},{"issue":"7","key":"890_CR65","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1537-2995.2003.t01-1-00434.x","volume":"43","author":"Hans H. Jung","year":"2003","unstructured":"Jung HH, Hergersberg M, Vogt M, Pahnke J, Treyer V, R\u00f6thlisberger B, Kollias SS, Russo D, Frey BM. McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement. Transfus. 2003;43(7):928\u201338.","journal-title":"Transfusion"},{"issue":"18","key":"890_CR66","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000310985.40011.d6","volume":"70","author":"A McNeill","year":"2008","unstructured":"McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008;70(18):1614\u20139.","journal-title":"Neurology"},{"issue":"24","key":"890_CR67","doi-asserted-by":"crossref","first-page":"2145 LP-2146","DOI":"10.1212\/01.wnl.0000437304.30227.bd","volume":"81","author":"K Fujita","year":"2013","unstructured":"Fujita K, Osaki Y, Harada M, Kono S, Miyajima H, Izumi Y, et al. Brain and liver iron accumulation in aceruloplasminemia. Neurology. 2013;81(24):2145 LP-2146.","journal-title":"Neurology"},{"key":"890_CR68","unstructured":"Miyajima H. Aceruloplasminemia. 2003 Aug 12 [Updated 2015 Nov 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae. Seattle (WA): University of Washington; 1993-2018. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1493\/ ."},{"issue":"6","key":"890_CR69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrn1119","volume":"4","author":"D Bihan Le","year":"2003","unstructured":"Le Bihan D. Looking into the functional archetecture of the brain with diffusion MRI. Nat Rev Neurosci. 2003;4(6):469\u201380.","journal-title":"Nat Rev Neurosci"},{"issue":"9558","key":"890_CR70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(07)60151-2","volume":"369","author":"JA Chalela","year":"2007","unstructured":"Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (London, England). 2007;369(9558):293\u20138.","journal-title":"Lancet (London, England)"},{"key":"890_CR71","unstructured":"U.S. Department of Health and Human Services Food and Drug and A. for D. E. and R. (CEDR). Guidance for industry: qualification process for drug development tools. 2014."},{"issue":"5","key":"890_CR72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00234-015-1500-1","volume":"57","author":"M Viallon","year":"2015","unstructured":"Viallon M, Cuvinciuc V, Delattre B, Merlini L, Barnaure-Nachbar I, Toso-Patel S, et al. State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications. Neuroradiology. 2015;57(5):441\u201367.","journal-title":"Neuroradiology"},{"issue":"5","key":"890_CR73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00234-018-2012-6","volume":"60","author":"AF Geraldo","year":"2018","unstructured":"Geraldo AF, Pereira J, Nunes P, Reimao S, Sousa R, Castelo-Branco M, et al. Beyond fractional anisotropy in amyotrophic lateral sclerosis: the value of mean, axial, and radial diffusivity and its correlation with electrophysiological conductivity changes. Neuroradiology. 2018;60(5):505\u201315.","journal-title":"Neuroradiology"},{"issue":"9","key":"890_CR74","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e318284070c","volume":"80","author":"CJ Cochrane","year":"2013","unstructured":"Cochrane CJ, Ebmeier KP. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology. 2013;80(9):857\u201364.","journal-title":"Neurology"},{"key":"890_CR75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nicl.2016.07.003","volume":"12","author":"A Klistorner","year":"2016","unstructured":"Klistorner A, Wang C, Fofanova V, Barnett MH, Yiannikas C, Parratt J, et al. Diffusivity in multiple sclerosis lesions: at the cutting edge? NeuroImage Clin. 2016;12:219\u201326.","journal-title":"NeuroImage Clin"},{"issue":"9","key":"890_CR76","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.neurobiolaging.2015.05.011","volume":"36","author":"ER Lindemer","year":"2015","unstructured":"Lindemer ER, Salat DH, Smith EE, Nguyen K, Fischl B, Greve DN. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer\u2019s disease from nonconverters. Neurobiol Aging. 2015;36(9):2447\u201357.","journal-title":"Neurobiol Aging"},{"issue":"November 2017","key":"890_CR77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eplepsyres.2017.11.010","volume":"140","author":"F Deleo","year":"2018","unstructured":"Deleo F, Thom M, Concha L, Bernasconi A, Bernhardt BC, Bernasconi N. Histological and MRI markers of white matter damage in focal epilepsy. Epilepsy Res. 2018;140(November 2017):29\u201338.","journal-title":"Epilepsy Res"},{"key":"890_CR78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.parkreldis.2016.09.005","volume":"32","author":"W Liu","year":"2016","unstructured":"Liu W, Yang J, Burgunder JM, Cheng B, Shang H. Diffusion imaging studies of Huntington\u2019s disease: a meta-analysis. Park Relat Disord. 2016;32:94\u2013101.","journal-title":"Park Relat Disord"},{"issue":"4","key":"890_CR79","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuroimage.2009.03.044","volume":"46","author":"G Douaud","year":"2009","unstructured":"Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, et al. In vivo evidence for the selective subcortical degeneration in Huntington\u2019s disease. Neuroimage. 2009;46(4):958\u201366.","journal-title":"Neuroimage"},{"issue":"7","key":"890_CR80","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hbm.22019","volume":"34","author":"C S\u00e1nchez-Casta\u00f1eda","year":"2013","unstructured":"S\u00e1nchez-Casta\u00f1eda C, Cherubini A, Elifani F, P\u00e9ran P, Orobello S, Capelli G, et al. Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp. 2013;34(7):1625\u201335.","journal-title":"Hum Brain Mapp"},{"issue":"9","key":"890_CR81","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","volume":"21","author":"HD Rosas","year":"2006","unstructured":"Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, et al. Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: selective white matter pathology and its relationship to clinical measures. Mov Disord. 2006;21(9):1317\u201325.","journal-title":"Mov Disord"},{"issue":"4","key":"890_CR82","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.neuroimage.2009.10.015","volume":"49","author":"HD Rosas","year":"2010","unstructured":"Rosas HD, Lee SY, Bender AC, Zaleta AK, Vangel M, Yu P, et al. Altered white matter microstructure in the corpus callosum in Huntington\u2019s disease: implications for cortical \u2018disconnection,\u2019. Neuroimage. 2010;49(4):2995\u20133004.","journal-title":"Neuroimage"},{"issue":"4","key":"890_CR83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JHD-130077","volume":"2","author":"HE Crawford","year":"2013","unstructured":"Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, et al. Corpus callosal atrophy in premanifest and early Huntington\u2019s disease. J Huntingtons Dis. 2013;2(4):517\u201326.","journal-title":"J Huntingtons Dis"},{"key":"890_CR84","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nicl.2016.02.014","volume":"11","author":"AV Faria","year":"2016","unstructured":"Faria AV, Ratnanather JT, Tward DJ, Lee DS, Van Den Noort F, Wu D, et al. Linking white matter and deep gray matter alterations in premanifest Huntington disease. NeuroImage Clin. 2016;11:450\u201360.","journal-title":"NeuroImage Clin"},{"issue":"7","key":"890_CR85","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.20868","volume":"21","author":"K Seppi","year":"2006","unstructured":"Seppi K, Schocke MFH, Mair KJ, Esterhammer R, Weirich-Schwaiger H, Utermann B, et al. Diffusion-weighted imaging in Huntington\u2019s disease. Mov Disord. 2006;21(7):1043\u20137.","journal-title":"Mov Disord"},{"issue":"6","key":"890_CR86","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/mrm.1910360612","volume":"36","author":"C Pierpaoli","year":"1996","unstructured":"Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med. 1996;36(6. New York):893\u2013906.","journal-title":"Magn Reson Med"},{"issue":"10","key":"890_CR87","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1002\/hbm.23713","volume":"38","author":"D Wu","year":"2017","unstructured":"Wu D, Faria AV, Younes L, Mori S, Brown T, Johnson H, et al. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington\u2019s disease. Hum Brain Mapp. 2017;38(10):5035\u201350.","journal-title":"Hum Brain Mapp"},{"key":"890_CR88","first-page":"ecurrents.hd.f1","volume":"6","author":"JH Cole","year":"2014","unstructured":"Cole JH, Farmer RE, Rees EM, Johnson HJ, Frost C, Scahill RI, et al. Test-retest reliability of diffusion tensor imaging in Huntington\u2019s disease. PLoS Curr. 2014;6:ecurrents.hd.f19ef63fff962f5cd9c0e88f4844f43b.","journal-title":"PLoS Curr"},{"issue":"1","key":"890_CR89","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","volume":"74","author":"GR Poudel","year":"2015","unstructured":"Poudel GR, Stout JC, Dom\u00ednguez DJF, Churchyard A, Chua P, Egan GF, et al. Longitudinal change in white matter microstructure in Huntington\u2019s disease: the IMAGE-HD study. Neurobiol Dis. 2015;74(1):406\u201312.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"890_CR90","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/hbm.22756","volume":"36","author":"OFF Odish","year":"2015","unstructured":"Odish OFF, Leemans A, Reijntjes RHAM, van den Bogaard SJA, Dumas EM, Wolterbeek R, et al. Microstructural brain abnormalities in Huntington\u2019s disease: a two-year follow-up. Hum Brain Mapp. 2015;36(6):2061\u201374.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"890_CR91","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hbm.23465","volume":"38","author":"JJ Shaffer","year":"2017","unstructured":"Shaffer JJ, Ghayoor A, Long JD, Kim REY, Lourens S, O\u2019Donnell LJ, et al. Longitudinal diffusion changes in prodromal and early HD: evidence of white-matter tract deterioration. Hum Brain Mapp. 2017;38(3):1460\u201377.","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"890_CR92","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0730-725X(00)00147-8","volume":"18","author":"AW Anderson","year":"2000","unstructured":"Anderson AW, Xie J, Pizzonia J, Bronen RA, Spencer DD, Gore JC. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging. 2000;18(6):689\u201395.","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"890_CR93","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0006-3495(93)81441-3","volume":"64","author":"S Ogawa","year":"1993","unstructured":"Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann JM, et al. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J. 1993;64(3):803\u201312.","journal-title":"Biophys J"},{"issue":"1424","key":"890_CR94","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1098\/rstb.2002.1114","volume":"357","author":"NK Logothetis","year":"2002","unstructured":"Logothetis NK. The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Philos Trans R Soc Lond Ser B Biol Sci. 2002;357(1424):1003\u201337.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"5","key":"890_CR95","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nn0508-523","volume":"11","author":"Y Nir","year":"2008","unstructured":"Nir Y, Dinstein I, Malach R, Heeger DJ. BOLD and spiking activity. Nat Neurosci. 2008;11(5):523\u20134 author reply 524.","journal-title":"Nat Neurosci"},{"issue":"4","key":"890_CR96","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mrm.1910340409","volume":"34","author":"B Biswal","year":"1995","unstructured":"Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med. 1995;34(4):537\u201341.","journal-title":"Magn Reson Med"},{"issue":"2","key":"890_CR97","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.neuroimage.2011.10.035","volume":"62","author":"RL Buckner","year":"2012","unstructured":"Buckner RL. The serendipitous discovery of the brain\u2019s default network. Neuroimage. 2012;62(2):1137\u201345.","journal-title":"Neuroimage"},{"issue":"1","key":"890_CR98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2009.198","volume":"6","author":"D Zhang","year":"2010","unstructured":"Zhang D, Raichle ME. Disease and the brain\u2019s dark energy. Nat Rev Neurol. 2010;6(1):15\u201328.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"890_CR99","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrneurol.2014.178","volume":"10","author":"M Pievani","year":"2014","unstructured":"Pievani M, Filippini N, van den Heuvel MP, Cappa SF, Frisoni GB. Brain connectivity in neurodegenerative diseases\u2014from phenotype to proteinopathy. Nat Rev Neurol. 2014;10(11):620\u201333.","journal-title":"Nat Rev Neurol"},{"issue":"March","key":"890_CR100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.nicl.2018.03.013","volume":"18","author":"C Hohenfeld","year":"2018","unstructured":"Hohenfeld C, Werner CJ, Reetz K. Resting-state connectivity in neurodegenerative disorders: is there potential for an imaging biomarker? NeuroImage Clin. 2018;18(March):849\u201370.","journal-title":"NeuroImage Clin"},{"issue":"1","key":"890_CR101","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nicl.2013.03.001","volume":"2","author":"EM Dumas","year":"2013","unstructured":"Dumas EM, van den Bogaard SJA, Hart EP, Soeter RP, van Buchem MA, van der Grond J, et al. Reduced functional brain connectivity prior to and after disease onset in Huntington\u2019s disease. NeuroImage Clin. 2013;2(1):377\u201384.","journal-title":"NeuroImage Clin"},{"issue":"2","key":"890_CR102","first-page":"87","volume":"39","author":"GR Poudel","year":"2014","unstructured":"Poudel GR, Egan GF, Churchyard A, Chua P, Stout JC, Georgiou-Karistianis N. Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study. J Psychiatry Neurosci. 2014;39(2):87\u201396.","journal-title":"J Psychiatry Neurosci"},{"issue":"8","key":"890_CR103","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/brain\/awv145","volume":"138","author":"DL Harrington","year":"2015","unstructured":"Harrington DL, Rubinov M, Durgerian S, Mourany L, Reece C, Koenig K, et al. Network topology and functional connectivity disturbances precede the onset of Huntington\u2019s disease. Brain. 2015;138(8):2332\u201346.","journal-title":"Brain"},{"issue":"11","key":"890_CR104","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/hbm.23299","volume":"37","author":"F Gargouri","year":"2016","unstructured":"Gargouri F, Mess\u00e9 A, Perlbarg V, Valabregue R, McColgan P, Yahia-Cherif L, et al. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest Huntington\u2019s disease. Hum Brain Mapp. 2016;37(11):4112\u201328.","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"890_CR105","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/hbm.22351","volume":"35","author":"CJ Werner","year":"2014","unstructured":"Werner CJ, Dogan I, Sa\u00df C, Mirzazade S, Schiefer J, Shah NJ, et al. Altered resting-state connectivity in Huntington\u2019s disease. Hum Brain Mapp. 2014;35(6):2582\u201393.","journal-title":"Hum Brain Mapp"},{"issue":"15","key":"890_CR106","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1017\/S0033291714000579","volume":"44","author":"RC Wolf","year":"2014","unstructured":"Wolf RC, Sambataro F, Vasic N, Depping MS, Thomann PA, Landwehrmeyer GB, et al. Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington\u2019s disease. Psychol Med. 2014;44(15):3341\u201356.","journal-title":"Psychol Med"},{"key":"890_CR107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1371\/journal.pone.0072159","volume":"8","author":"M Quarantelli","year":"2013","unstructured":"Quarantelli M, Salvatore E, Delle Acque Giorgio SM, Filla A, Cervo A, Russo CV, et al. Default-mode network changes in Huntington\u2019s disease: an integrated MRI study of functional connectivity and morphometry. PLoS One. 2013;8:8.","journal-title":"PLoS One"},{"key":"890_CR108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuroimage.2013.04.013","volume":"78","author":"R Patriat","year":"2013","unstructured":"Patriat R, Molloy EK, Meier TB, Kirk GR, Nair VA, Meyerand ME, et al. The effect of resting condition on resting-state fMRI reliability and consistency: a comparison between resting with eyes open, closed, and fixated. Neuroimage. 2013;78:463\u201373.","journal-title":"Neuroimage"},{"issue":"5810","key":"890_CR109","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.1131295","volume":"315","author":"MF Mason","year":"2007","unstructured":"Mason MF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN. Wandering minds: the default network and stimulus-independent thought. Science. 2007;315(5810):393\u20135.","journal-title":"Science"},{"issue":"2","key":"890_CR110","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2012.01.023","volume":"62","author":"DJ McGonigle","year":"2012","unstructured":"McGonigle DJ. Test-retest reliability in fMRI: or how I learned to stop worrying and love the variability. Neuroimage. 2012;62(2):1116\u201320.","journal-title":"Neuroimage"},{"issue":"7","key":"890_CR111","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/brain.2014.0284","volume":"4","author":"RM Birn","year":"2014","unstructured":"Birn RM, Cornejo MD, Molloy EK, Patriat R, Meier TB, Kirk GR, et al. The influence of physiological noise correction on test\u2013retest reliability of resting-state functional connectivity. Brain Connect. 2014;4(7):511\u201322.","journal-title":"Brain Connect"},{"key":"890_CR112","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.neuroimage.2013.09.013","volume":"84","author":"H Cao","year":"2014","unstructured":"Cao H, Plichta MM, Sch\u00e4fer A, Haddad L, Grimm O, Schneider M, et al. Test-retest reliability of fMRI-based graph theoretical properties during working memory, emotion processing, and resting state. Neuroimage. 2014;84:888\u2013900.","journal-title":"Neuroimage"},{"issue":"1","key":"890_CR113","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/hbm.22616","volume":"36","author":"OFF Odish","year":"2015","unstructured":"\u2022 Odish OFF, van den Berg-Huysmans AA, van den Bogaard SJA, Dumas EM, Hart EP, Rombouts SARB, et al. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington\u2019s disease gene carriers: a three-year follow-up study. Hum Brain Mapp. 2015;36(1):110\u20139 In this article, a well-designed longitudinal analysis of the resting-state fMRI (RS-fMRI) data revealed no differences in the degree of connectivity change between the groups over a period of 3\u00a0years, though a significantly higher rate of striatal atrophy was found in the pre-HD group compared to controls in the same period.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"890_CR114","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"Anne B. Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, Ehrenkaufer R, Jewett D, Hichwa R. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986;20(3):296\u2013303.","journal-title":"Annals of Neurology"},{"issue":"3","key":"890_CR115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"Anne B. Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-rubinstein S, Markel DS, Berent S, Giordani B, Ehrenkaufer R, Jewett D, PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline Ann Neurol. 1986;20:296\u2013303.","journal-title":"Annals of Neurology"},{"issue":"Pt 6","key":"890_CR116","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain. 1996;119(Pt 6):2085\u201395.","journal-title":"Brain"},{"issue":"12","key":"890_CR117","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","volume":"43","author":"DA L\u00f3pez-Mora","year":"2016","unstructured":"L\u00f3pez-Mora DA, Camacho V, P\u00e9rez-P\u00e9rez J, Mart\u00ednez-Horta S, Fern\u00e1ndez A, Sampedro F, et al. Striatal hypometabolism in premanifest and manifest Huntington\u2019s disease patients. Eur J Nucl Med Mol Imaging. 2016;43(12):2183\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"890_CR118","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med. 2006;47(2):215\u201322.","journal-title":"J Nucl Med"},{"issue":"9","key":"890_CR119","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","volume":"123","author":"CC Tang","year":"2013","unstructured":"\u2022\u2022 Tang CC, Feigin A, Ma Y, Habeck C, Paulsen JS, Leenders KL, et al. Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease. J Clin Invest. 2013;123(9):4076\u201388 In this study, 12 premanifest HD mutation carriers were scanned with [18F]-fluorodeoxyglucose PET to measure cerebral metabolic activity at baseline and again at 1.5, 4, and 7\u00a0years. In the premanifest cohort, network analysis disclosed a significant spatial covariance pattern characterized by progressive changes in striato-thalamic and cortical metabolic activity. In these subjects, network activity increased linearly over 7\u00a0years and was not influenced by intercurrent phenoconversion.","journal-title":"J Clin Invest"},{"key":"890_CR120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.410230603","volume":"23","author":"S Berent","year":"1988","unstructured":"Berent S, Giordani B, Lehtinen S, Markel D, Penney JB, Buchtel HA, et al. Positron emission tomographic scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of cognitive function. Ann Neurol. 1988;23:541\u20136.","journal-title":"Ann Neurol"},{"issue":"6","key":"890_CR121","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","volume":"39","author":"A Ciarmiello","year":"2012","unstructured":"Ciarmiello A, Giovacchini G, Orobello S, Bruselli L, Elifani F, Squitieri F. 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging. 2012;39(6):1030\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"890_CR122","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/RLU.0000000000000968","volume":"40","author":"R Cui","year":"2015","unstructured":"Cui R, You H, Niu N, Li F. Interesting image FDG PET brain scan demonstrated glucose hypometabolism of bilateral caudate nuclei and putamina in a patient with chorea-acanthocytosis. Clin Nucl Med. 2015;40(12):979\u201380. https:\/\/doi.org\/10.1097\/RLU.0000000000000968 .","journal-title":"Clin Nucl Med"},{"issue":"7","key":"890_CR123","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2967\/jnumed.111.101543","volume":"53","author":"K Brockmann","year":"2012","unstructured":"Brockmann K, Reimold M, Globas C, Hauser TK, Walter U, Machulla HJ, et al. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17. J Nucl Med. 2012;53(7):1074\u201381. https:\/\/doi.org\/10.2967\/jnumed.111.101543 .","journal-title":"J Nucl Med"},{"issue":"7","key":"890_CR124","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00415-002-0756-7","volume":"249","author":"W. Hermann","year":"2002","unstructured":"Hermann W, Barthel H, Hesse S, Grahmann F, K\u00fchn HJ, Wagner A, Villmann T. Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions. J Neurol 2002;249(7):896\u2013901.","journal-title":"Journal of Neurology"},{"issue":"7","key":"890_CR125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00415-002-0756-7","volume":"249","author":"W Hermann","year":"2002","unstructured":"Hermann W, Barthel H, Hesse S, Grahmann F, K\u00fchn HJ, Wagner A, et al. Comparison of clinical types of Wilson\u2019s disease and glucose metabolism in extrapyramidal motor brain regions. J Neurol. 2002;249(7):896\u2013901.","journal-title":"J Neurol"},{"issue":"1","key":"890_CR126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.870130127","volume":"13","author":"J Sund\u00e9n-Cullberg","year":"1998","unstructured":"Sund\u00e9n-Cullberg J, Tedroff J, Aquilonius SM. Reversible chorea in primary antiphospholipid syndrome. Mov Disord. 1998;13(1):147\u20139.","journal-title":"Mov Disord"},{"issue":"11","key":"890_CR127","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1007\/s00415-011-6069-y","volume":"258","author":"HC Huang","year":"2011","unstructured":"Huang HC, Wu YC, Shih LY, Lo WC, Tsai CH, Shyu WC. Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea. J Neurol. 2011;258(11):2054\u20137.","journal-title":"J Neurol"},{"issue":"4","key":"890_CR128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.870080404","volume":"8","author":"A Weindl","year":"1993","unstructured":"Weindl A, Kuwert T, Leenders KL, Poremba M, Gr\u00e4Fin von Einsiedel H, Antonini A, et al. Increased striatal glucose consumption in sydenham\u2019s chorea. Mov Disord. 1993;8(4):437\u201344.","journal-title":"Mov Disord"},{"issue":"Pt 3","key":"890_CR129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","volume":"120","author":"N Ginovart","year":"1997","unstructured":"Ginovart N, Lundin A, Farde L, Halldin C, Backman L, Swahn CG, et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease. Brain. 1997;120(Pt 3):503\u201314.","journal-title":"Brain"},{"issue":"Pt 3","key":"890_CR130","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/brain\/118.3.689","volume":"118","author":"N Turjanski","year":"1995","unstructured":"Turjanski N, Weeks R, Dolan R, Harding AE, Brooks DJ. Striatal D1 and D2 receptor binding in patients with Huntington\u2019s disease and other choreas. A PET study. Brain. 1995;118(Pt 3):689\u201396.","journal-title":"Brain"},{"key":"890_CR131","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","volume":"122","author":"TC Andrews","year":"1999","unstructured":"Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, et al. Huntington\u2019s disease progression. PET and clinical observations. Brain. 1999;122:2353\u201363.","journal-title":"Brain"},{"issue":"5","key":"890_CR132","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","volume":"126","author":"N Pavese","year":"2003","unstructured":"Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: a pet study. Brain. 2003;126(5):1127\u201335.","journal-title":"Brain"},{"issue":"6","key":"890_CR133","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","volume":"65","author":"JCH Oostrom van","year":"2005","unstructured":"van Oostrom JCH, Maguire RP, Verschuuren-Bemelmans CC, Veenma-van der Duin L, Pruim J, Roos RAC, et al. Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology. 2005;65(6):941\u20133.","journal-title":"Neurology"},{"issue":"2","key":"890_CR134","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2009.10.015","volume":"37","author":"N Pavese","year":"2010","unstructured":"Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, et al. Cortical dopamine dysfunction in symptomatic and premanifest Huntington\u2019s disease gene carriers. Neurobiol Dis. 2010;37(2):356\u201361.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"890_CR135","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/hbm.21134","volume":"32","author":"M Esmaeilzadeh","year":"2011","unstructured":"Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, et al. Extrastriatal dopamine D(2) receptor binding in Huntington\u2019s disease. Hum Brain Mapp. 2011;32(10):1626\u201336.","journal-title":"Hum Brain Mapp"},{"issue":"9","key":"890_CR136","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/WNL.54.9.1753","volume":"54","author":"NI Bohnen","year":"2000","unstructured":"Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, et al. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 2000;54(9):1753\u20139.","journal-title":"Neurology"},{"issue":"1","key":"890_CR137","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.110.173294","volume":"336","author":"RJ Kleiman","year":"2011","unstructured":"Kleiman RJ, Kimmel LH, Bove SE, Lanz TA, Harms JF, Romegialli A, et al. Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington\u2019s disease. J Pharmacol Exp Ther. 2011;336(1):64\u201376.","journal-title":"J Pharmacol Exp Ther"},{"key":"890_CR138","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/1381612820666140826114744","volume":"21","author":"LS Wilson","year":"2015","unstructured":"Wilson LS, Brandon NJ. Emerging biology of PDE10A. Curr Pharm Des. 2015;21:378\u201388.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"890_CR139","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","volume":"54","author":"TM Coskran","year":"2006","unstructured":"Coskran TM, Morton D, Menniti FS, Adamowicz WO, Kleiman RJ, Ryan AM, et al. Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J Histochem Cytochem. 2006;54(11):1205\u201313.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"890_CR140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","volume":"92","author":"V Beaumont","year":"2016","unstructured":"\u2022\u2022 Beaumont V, Zhong S, Lin H, Xu W, Bradaia A, Steidl E, et al. Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington\u2019s disease models. Neuron. 2016;92(6):1220\u201337 An important preclinical milestones demonstrating the benefit of pharmacologic PDE10 inhibition to acutely correct basal ganglia circuitry deficits in Huntington\u2019s disease models.","journal-title":"Neuron"},{"key":"890_CR141","doi-asserted-by":"crossref","unstructured":"\u2022 Niccolini F, Pagano G, Fusar-Poli P, Wood A, Mrzljak L, Sampaio C, Politis M Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies. J Neurol Neurosurg Psychiatry. 2017;jnnp-2017-316633. A relevant systematic review and meta-analysis of PET studies in HD.","DOI":"10.1136\/jnnp-2017-316633"},{"issue":"3","key":"890_CR142","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.0000000000000037","volume":"82","author":"R. Ahmad","year":"2013","unstructured":"Ahmad R, Bourgeois S, Postnov A, Schmidt ME, Bormans G, Van Laere K, et al. PET imaging shows loss of striatal PDE10A in patients with Huntington disease. Neurology. 2014;82(3):279\u201381.","journal-title":"Neurology"},{"issue":"12","key":"890_CR143","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","volume":"71","author":"DS Russell","year":"2014","unstructured":"Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, et al. The phosphodiesterase 10 positron emission tomography tracer, [18 F]MNI-659, as a novel biomarker for early Huntington disease. JAMA Neurol. 2014;71(12):1520\u201328. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1954 .","journal-title":"JAMA Neurol"},{"issue":"8","key":"890_CR144","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1212\/WNL.0000000000002391","volume":"86","author":"DS Russell","year":"2016","unstructured":"Russell DS, Jennings DL, Barret O, Tamagnan GD, Carroll VM, Caille F, et al. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging. Neurology. 2016;86(8):748\u201354.","journal-title":"Neurology"},{"issue":"10","key":"890_CR145","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/brain\/awv214","volume":"138","author":"Flavia Niccolini","year":"2015","unstructured":"\u2022\u2022 Niccolini F, Haider S, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, et al. Altered PDE10A expression detectable early before symptomatic onset in Huntington\u2019s disease. Brain. 138(10):3016\u201329, 2015 This article is the most recent application of PDE10A molecular imaging in HD mutation carriers. It showed reduced PD10A availabilities in the premanifest phase of HD.","journal-title":"Brain"},{"key":"890_CR146","unstructured":"Fazio P, Bronzova J, Nag S, Warner J, Landwehrmeyer B, Halldin C, Mrzljak L. Imaging of phosphodiesterase 10 A (PDE10A) enzyme levels in the living human brain of Huntington\u2019 s disease gene expansion carriers and healthy controls with positron emission tomography. [abstract] in Mov Disord, 2017;1\u20132."},{"key":"890_CR147","doi-asserted-by":"crossref","unstructured":"Varrone A, Fazio P, Fitzer-Attas C, Mrzljak L, Martisson S, Landwehrmeyer GB, Bronzova J, Al-Tawil N, Halldin C, Sampaio C. Positron emission tomography imaging of phosphodiesterase 10 A enzyme and dopamine D2 receptor in Huntington\u2019s disease gene expansion carriers. J Neurol Neurosurg Psychiatry. 2014;85(Suppl 1).","DOI":"10.1136\/jnnp-2014-309032.134"},{"issue":"6","key":"890_CR148","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","volume":"43","author":"Gennaro Pagano","year":"2016","unstructured":"Pagano G, Niccolini F, Politis M. Current status of PET imaging in Huntington's disease. Eur J Nucl Med Mol Imaging 2016;43(6):1171\u201382. https:\/\/doi.org\/10.1007\/s00259-016-3324-6 .","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"12","key":"890_CR149","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.neurobiolaging.2014.06.010","volume":"35","author":"M Ooms","year":"2014","unstructured":"Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, et al. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10a activity in vivo in R6\/2 Huntington mice. Neurobiol Aging. 2014;35(12):2858\u201369.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"890_CR150","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.expneurol.2011.03.014","volume":"229","author":"C. Casteels","year":"2011","unstructured":"Casteels C, Vandeputte C, Rangarajan JR, Dresselaers T, Riess O, Bormans G, Maes F, Himmelreich U, Nguyen H, Van Laere K. Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease. Exp Neurol 2011 229(2):440\u2013449.","journal-title":"Experimental Neurology"},{"issue":"9","key":"890_CR151","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","volume":"51","author":"K Laere Van","year":"2010","unstructured":"Van Laere K, Casteels C, Dhollander I, Goffin K, Grachev I, Bormans G, et al. Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo. J Nucl Med. 2010;51(9):1413\u20137.","journal-title":"J Nucl Med"},{"issue":"September 2015","key":"890_CR152","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/mtna.2016.7","volume":"5","author":"J Miniarikova","year":"2016","unstructured":"Miniarikova J, Zanella I, Huseinovic A, van der Zon T, Hanemaaijer E, Martier R, et al. Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington\u2019s disease. Mol Ther - Nucleic Acids. 2016;5(September 2015):e297.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"890_CR153","doi-asserted-by":"crossref","unstructured":"Mestre TA, Sampaio C. Huntington disease: linking pathogenesis to the development of experimental therapeutics. Curr Neurol Neurosci Rep. 2017;17(2).","DOI":"10.1007\/s11910-017-0711-8"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-018-0890-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T21:43:32Z","timestamp":1605131012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-018-0890-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":153,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s11910-018-0890-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"5 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Andrea Varrone reports grants from CHDI Foundation, during the conduct of the study. Per Svenningsson reports grants from Stockholm City Council, grants from Knut och Alice Wallenberg Stiftelse, during the conduct of the study; personal fees from AbbVie, outside the submitted work. Patrik Fazio and Martin Paucar each declare no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"85"}}